SAB Biotherapeutics Ratios (2020-2026) | SABS

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-16.15%-27.66%-104.46%9.13%-76.66%-197.12%-363.23%-1,265.50%-8,046.13%-402.59%-7,493.75%-532.06%-2,787.69%-8,669.15%
EBIT Margin (Quarter)
-15.77%-27.18%-66.41%-56.83%-103.03%-217.49%792.62%-1,273.79%-7,573.40%-420.00%-6,187.90%-1,205.90%-3,876.95%-8,726.26%
EBITDA Margin (Quarter)
-15.77%-27.18%-66.41%-56.83%-103.03%-217.49%792.62%-1,273.79%-7,573.40%-420.00%-6,187.90%-1,205.90%-3,876.95%-8,726.26%
Operating Margin (Quarter)
-15.77%-27.18%-66.41%-56.83%-103.03%-217.49%792.62%-1,273.79%-7,573.40%-420.00%-6,187.90%-1,205.90%-3,876.95%-8,726.26%
Net Margin (Quarter)
-16.15%-27.66%-104.46%8.35%-75.21%-197.12%-364.42%-1,265.50%-8,046.13%-402.59%-7,493.75%-532.06%-2,787.69%-9,934.52%
FCF Margin (Quarter)
-54.09%3.88%-65.47%-92.31%-79.69%-222.78%-77.41%-279.99%-5,755.33%-414.49%-4,430.85%-1,151.74%-2,952.95%-8,358.96%
Efficiency
Assets Average (Quarter)
117.18M117.01M99.03M74.81M63.95M55.96M51.71M46.79M39.06M31.89M56.14M77.66M66.63M57.84M49.00M41.16M34.12M106.79M178.13M210.64M
Equity Average (Quarter)
39.51M36.67M36.81M39.90M39.19M33.87M30.84M27.73M22.06M17.49M36.28M55.06M49.47M41.51M31.44M23.69M16.71M88.55M158.28M189.37M
Invested Capital (Quarter)
38.26M35.08M42.47M41.26M37.12M30.62M34.82M28.13M23.33M15.26M57.30M52.82M46.12M36.90M25.97M21.41M12.02M165.07M151.49M227.25M
Asset Utilization Ratio (Quarter)
0.610.750.690.590.460.270.160.130.040.030.040.030.03
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-38.59-50.80-110.81-93.13-91.85-110.54195.30-80.12-85.99-76.37-242.35-149.15-109.56-144.92-141.22-154.85-151.25-292.87-248.50-318.71
Debt to Equity (Quarter)
0.02
Debt Ratio (Quarter)
0.01
Equity Ratio (Quarter)
0.330.300.480.600.620.580.610.570.560.540.680.740.750.690.590.560.400.900.880.91
Times Interest Earned (Quarter)
-38.59-50.80-110.81-93.13-91.85-110.54195.30-80.12-85.99-76.37-242.35-149.15-109.56-144.92-141.22-154.85-151.25-292.87-248.50-318.71
Valuation
Enterprise Value (Quarter)
-10.23M-10.75M-39.55M-22.41M-16.62M-8.33M-15.05M-13.06M-7.77M-2.43M-56.57M-44.06M-37.24M-30.40M-20.76M-12.85M-5.71M-110.88M-96.59M-107.39M
Return Ratios
Return on Sales (Quarter)
0.00%0.00%-0.01%0.00%-0.01%-0.02%-0.04%-0.13%-0.80%-0.04%-0.75%-0.05%-0.28%-0.30%-0.87%
Return on Capital Employed (Quarter)
-18.45%-37.65%-51.70%-73.09%-10.71%-13.96%-16.25%-9.15%-84.00%-60.65%-77.50%-105.60%-104.62%-134.24%-178.37%-44.99%-29.23%-28.98%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%0.00%0.00%0.00%